Lv2
128 积分 2024-10-10 加入
Application of Quantitative Systems Pharmacology Approaches to Support Pediatric Labeling in Rare Diseases
1天前
已完结
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
2天前
求助中
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
3天前
已完结
Clinical Translation of Targeted Protein Degraders
6天前
已完结
Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease
14天前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
19天前
已完结
Sotorasib’s Accelerated Approval
28天前
已完结
Cytokine Mimetics with Various Modalities
1个月前
已完结
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
2个月前
已完结
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations
3个月前
已完结
皖公网安备34019202002308
